Farmácia Popular Program: pharmaceutical market analysis of antihypertensive acting on the renin-angiotensin system medicines
Autor(a) principal: | |
---|---|
Data de Publicação: | 2017 |
Outros Autores: | , , , , , , |
Tipo de documento: | Artigo |
Idioma: | eng |
Título da fonte: | Ciência & Saúde Coletiva (Online) |
Texto Completo: | http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1413-81232017002802501 |
Resumo: | Abstract This paper aims to analyse changes in the retail pharmaceutical market following policy changes in the Farmácia Popular Program (FP), a medicines subsidy program in Brazil. The retrospective longitudinal analyses focus on therapeutic class of agents acting on the renin-angiotensin system. Data obtained from QuintilesIMS (formerly IMS Health) included private retail pharmacy sales volume (pharmaceutical units) and sales values from 2002 to 2013. Analyses evaluated changes in market share following key FP policy changes. The therapeutic class was selected due to its relevance to hypertension treatment. Market share was analysed by therapeutic sub-classes and by individual company. Losartan as a single product accounted for the highest market share among angiotensin II antagonists. National companies had higher sales volume during the study period, while multinational companies had higher sales value. Changes in pharmaceutical market share coincided with the inclusion of specific products in the list of medicines covered by FP and with increases in or exemption from patient copayment. |
id |
ABRASCO-2_510a53aca53850fe79d77ccd25330d4a |
---|---|
oai_identifier_str |
oai:scielo:S1413-81232017002802501 |
network_acronym_str |
ABRASCO-2 |
network_name_str |
Ciência & Saúde Coletiva (Online) |
repository_id_str |
|
spelling |
Farmácia Popular Program: pharmaceutical market analysis of antihypertensive acting on the renin-angiotensin system medicinesPharmaceutical tradeAntihypertensive agentsInterrupted time series analysisPharmaceutical servicesGovernment programsAbstract This paper aims to analyse changes in the retail pharmaceutical market following policy changes in the Farmácia Popular Program (FP), a medicines subsidy program in Brazil. The retrospective longitudinal analyses focus on therapeutic class of agents acting on the renin-angiotensin system. Data obtained from QuintilesIMS (formerly IMS Health) included private retail pharmacy sales volume (pharmaceutical units) and sales values from 2002 to 2013. Analyses evaluated changes in market share following key FP policy changes. The therapeutic class was selected due to its relevance to hypertension treatment. Market share was analysed by therapeutic sub-classes and by individual company. Losartan as a single product accounted for the highest market share among angiotensin II antagonists. National companies had higher sales volume during the study period, while multinational companies had higher sales value. Changes in pharmaceutical market share coincided with the inclusion of specific products in the list of medicines covered by FP and with increases in or exemption from patient copayment.ABRASCO - Associação Brasileira de Saúde Coletiva2017-08-01info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersiontext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S1413-81232017002802501Ciência & Saúde Coletiva v.22 n.8 2017reponame:Ciência & Saúde Coletiva (Online)instname:Associação Brasileira de Saúde Coletiva (ABRASCO)instacron:ABRASCO10.1590/1413-81232017228.01442017info:eu-repo/semantics/openAccessSilva,Rondineli Mendes daChaves,Gabriela CostaChaves,Luisa ArueiraCampos,Mônica RodriguesLuiza,Vera LuciaBertoldi,Andréa DâmasoRoss-Degnan,DennisEmmerick,Isabel Cristina Martinseng2017-08-02T00:00:00Zoai:scielo:S1413-81232017002802501Revistahttp://www.cienciaesaudecoletiva.com.brhttps://old.scielo.br/oai/scielo-oai.php||cienciasaudecoletiva@fiocruz.br1678-45611413-8123opendoar:2017-08-02T00:00Ciência & Saúde Coletiva (Online) - Associação Brasileira de Saúde Coletiva (ABRASCO)false |
dc.title.none.fl_str_mv |
Farmácia Popular Program: pharmaceutical market analysis of antihypertensive acting on the renin-angiotensin system medicines |
title |
Farmácia Popular Program: pharmaceutical market analysis of antihypertensive acting on the renin-angiotensin system medicines |
spellingShingle |
Farmácia Popular Program: pharmaceutical market analysis of antihypertensive acting on the renin-angiotensin system medicines Silva,Rondineli Mendes da Pharmaceutical trade Antihypertensive agents Interrupted time series analysis Pharmaceutical services Government programs |
title_short |
Farmácia Popular Program: pharmaceutical market analysis of antihypertensive acting on the renin-angiotensin system medicines |
title_full |
Farmácia Popular Program: pharmaceutical market analysis of antihypertensive acting on the renin-angiotensin system medicines |
title_fullStr |
Farmácia Popular Program: pharmaceutical market analysis of antihypertensive acting on the renin-angiotensin system medicines |
title_full_unstemmed |
Farmácia Popular Program: pharmaceutical market analysis of antihypertensive acting on the renin-angiotensin system medicines |
title_sort |
Farmácia Popular Program: pharmaceutical market analysis of antihypertensive acting on the renin-angiotensin system medicines |
author |
Silva,Rondineli Mendes da |
author_facet |
Silva,Rondineli Mendes da Chaves,Gabriela Costa Chaves,Luisa Arueira Campos,Mônica Rodrigues Luiza,Vera Lucia Bertoldi,Andréa Dâmaso Ross-Degnan,Dennis Emmerick,Isabel Cristina Martins |
author_role |
author |
author2 |
Chaves,Gabriela Costa Chaves,Luisa Arueira Campos,Mônica Rodrigues Luiza,Vera Lucia Bertoldi,Andréa Dâmaso Ross-Degnan,Dennis Emmerick,Isabel Cristina Martins |
author2_role |
author author author author author author author |
dc.contributor.author.fl_str_mv |
Silva,Rondineli Mendes da Chaves,Gabriela Costa Chaves,Luisa Arueira Campos,Mônica Rodrigues Luiza,Vera Lucia Bertoldi,Andréa Dâmaso Ross-Degnan,Dennis Emmerick,Isabel Cristina Martins |
dc.subject.por.fl_str_mv |
Pharmaceutical trade Antihypertensive agents Interrupted time series analysis Pharmaceutical services Government programs |
topic |
Pharmaceutical trade Antihypertensive agents Interrupted time series analysis Pharmaceutical services Government programs |
description |
Abstract This paper aims to analyse changes in the retail pharmaceutical market following policy changes in the Farmácia Popular Program (FP), a medicines subsidy program in Brazil. The retrospective longitudinal analyses focus on therapeutic class of agents acting on the renin-angiotensin system. Data obtained from QuintilesIMS (formerly IMS Health) included private retail pharmacy sales volume (pharmaceutical units) and sales values from 2002 to 2013. Analyses evaluated changes in market share following key FP policy changes. The therapeutic class was selected due to its relevance to hypertension treatment. Market share was analysed by therapeutic sub-classes and by individual company. Losartan as a single product accounted for the highest market share among angiotensin II antagonists. National companies had higher sales volume during the study period, while multinational companies had higher sales value. Changes in pharmaceutical market share coincided with the inclusion of specific products in the list of medicines covered by FP and with increases in or exemption from patient copayment. |
publishDate |
2017 |
dc.date.none.fl_str_mv |
2017-08-01 |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article |
dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1413-81232017002802501 |
url |
http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1413-81232017002802501 |
dc.language.iso.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
10.1590/1413-81232017228.01442017 |
dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
text/html |
dc.publisher.none.fl_str_mv |
ABRASCO - Associação Brasileira de Saúde Coletiva |
publisher.none.fl_str_mv |
ABRASCO - Associação Brasileira de Saúde Coletiva |
dc.source.none.fl_str_mv |
Ciência & Saúde Coletiva v.22 n.8 2017 reponame:Ciência & Saúde Coletiva (Online) instname:Associação Brasileira de Saúde Coletiva (ABRASCO) instacron:ABRASCO |
instname_str |
Associação Brasileira de Saúde Coletiva (ABRASCO) |
instacron_str |
ABRASCO |
institution |
ABRASCO |
reponame_str |
Ciência & Saúde Coletiva (Online) |
collection |
Ciência & Saúde Coletiva (Online) |
repository.name.fl_str_mv |
Ciência & Saúde Coletiva (Online) - Associação Brasileira de Saúde Coletiva (ABRASCO) |
repository.mail.fl_str_mv |
||cienciasaudecoletiva@fiocruz.br |
_version_ |
1754213040630267904 |